Chief Scientific Officer
Sword Bio
Hebron, New Hampshire
Jim McNally, Ph.D - Chief Scientific Officer, Sword Bio
Dr. McNally has an extensive background in bioanalytical assay development and program leadership spanning nearly 20 years working in the pharmaceutical and biotechnology industry. Prior to joining Sword Bio, Dr. McNally was Chief Scientific Officer for BioAgilytix for 5 years leading scientific innovation and strategy. He has also previously held roles at Genzyme, Pfizer, EMD Serono, Shire and CRISPR Therapeutics which have given him broad experience in the development of large molecule, gene therapy, and cell therapy biotherapeutics. Dr. McNally is a recognized thought leader in the development and application of bioanalytical methods used in regulatory submissions and is specifically skilled in progression of biotherapeutics from research through clinical development. He has a special interest in the immunogenicity of biotherapeutics and leads an industry-wide working group to address this issue. A key part of his role at BioAgilytix is advising on emerging scientific developments and providing scientific and regulatory guidance. Dr. McNally obtained his B.S. in Biology from Mississippi State University, his Ph.D. Viral Immunology from Louisiana State University School of Medicine in Shreveport, and his Post-Doc in Viral Immunology from University of Massachusetts Medical School.
Disclosure information not submitted.
Immunogenicity and AAV Gene Therapies
Tuesday, July 14, 2026
8:05 AM - 8:35 AM East Coast USA Time